Wedbush Securities’s Clover Health Investments CLOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-46,000
Closed -$128K 1183
2025
Q2
$128K Buy
46,000
+25,000
+119% +$82.2K ﹤0.01% 1098
2025
Q1
$75K Buy
21,000
+11,000
+110% +$44.2K ﹤0.01% 1076
2024
Q4
$32K Sell
10,000
-161,000
-94% -$575K ﹤0.01% 1123
2024
Q3
$482K Buy
+171,000
New +$391K 0.02% 621
2024
Q1
Sell
-10,000
Closed -$10K 1242
2023
Q4
$10K Hold
10,000
﹤0.01% 1083
2023
Q3
$11K Hold
10,000
﹤0.01% 1053
2023
Q2
$9K Sell
10,000
-3,000
-23% -$2.66K ﹤0.01% 1060
2023
Q1
$11K Buy
+13,000
New +$14.2K ﹤0.01% 1068

Other funds holding CLOV

Wedbush Securities's CLOV Position: Q3 2025 in Review

Wedbush Securities sold out of Clover Health Investments (CLOV) in Q3 2025, closing a stake of 46,000 shares — an estimated $128K sold.

Wedbush Securities first reported a position in CLOV in Q1 2023 and held it in 8 quarters. The position peaked at $482K in Q3 2024. 201 funds tracked by Wall St. Rank hold CLOV as of Q3 2025.

  • Wedbush Securities reported no remaining Clover Health Investments position as of Q3 2025 after selling out during the quarter.
  • Wedbush Securities sold 46,000 Clover Health Investments shares in Q3 2025, an estimated $128K.
  • Wedbush Securities first reported a position in Clover Health Investments in Q1 2023 and held it in 8 quarters.
  • Wedbush Securities's Clover Health Investments position peaked at $482K in Q3 2024.
  • 201 funds tracked by Wall St. Rank held Clover Health Investments as of Q3 2025.

Based on Wedbush Securities's 13F filing for Q3 2025, filed 6 Nov 2025.